nprnews_____ = ||| lubuntu at wor2|||New Coronavirus Vaccine Candidate Shows Promise In Early, Limited Trial||| kickerpage = |||no kicker pagenpr for NPRNEWS||| summarynpr = |||Cambridge, Mass.-based Moderna, Inc. is reporting preliminary data suggesting its COVID-19 vaccine is safe and appears to be triggering an immune response in test subjects.

A view of Moderna headquarters in Cambridge, Mass., earlier this month. Moderna is touting preliminary data from a limited coronavirus vaccine trial.



Maddie Meyer/Getty Images


hide caption

toggle caption

Maddie Meyer/Getty Images

Coronavirus Live Updates

New Coronavirus Vaccine Candidate Shows Promise In Early, Limited Trial

Cambridge, Mass.-based Moderna, Inc. is reporting preliminary data suggesting its COVID-19 vaccine is safe and appears to be triggering an immune response in test subjects.